Li HE, Xiwei ZHAO, Gang CHEN, et al. Value of interferon-gamma release assay in pulmonary tuberculosis[J]. Journal of Third Military Medical University, 2017, 39(20): 2017-2021.
DOI:
Li HE, Xiwei ZHAO, Gang CHEN, et al. Value of interferon-gamma release assay in pulmonary tuberculosis[J]. Journal of Third Military Medical University, 2017, 39(20): 2017-2021. DOI: 10.16016/j.1000-5404.201706009.
Value of interferon-gamma release assay in pulmonary tuberculosis
① 单用IGRA不能鉴别陈旧性肺结核与活动性肺结核,应联合其他检测手段;② 若菌阳但IGRA阴性的肺疾病患者要考虑病原菌为非结核分枝杆菌的可能,应进一步行分枝杆菌菌种鉴定;③ 既往无结核病史的特殊人群(如孕妇)IGRA阳性有利于辅助诊断活动性结核病。
Abstract
Objective
2
To investigate the diagnostic value of interferon-gamma release assay (IGRA) in different types of pulmonary tuberculosis (TB).
Methods
2
IGRA was performed in 1 449 hospitalized patients in our hospital and the People's Hospital of Chongqing from January 1
2015 to December 31
2016. The sensitivity of IGRA for diagnosis of TB was evaluated
specifically in patients with TB
active TB
old TB
and other pulmonary diseases
as well as TB in special population.
Results
2
The sensitivity of IGRA in patients with TB (84.4%) was significantly different from the patients with other pulmonary diseases (
P
<
0.05); however
no significant difference was seen in the sensitivity between active TB (85.6%) and old TB (79.7%
P
>
0.05). In sputum smear-positive and smear-negative TBs
the sensitivity of IGRA was respective 85.1% and 86.6%
which was not statistically different (
P
>
0.05). There were 25 cases tested as sputum smear-positive but IGRA-negative. Among them
80% (20 cases) were
Mycobacterium tuberculosis
and 20% (5 cases) were non-tuberculosis mycobacterium. Four cases of pregnant women with TB were all IGRA-positive (100%).
Conclusion
2
Our results showed that: ① active TB and old TB cannot be differentially diagnosed by IGRA alone
Other examinations should be combined to improve the diagnosis accuracy; ② Patient with sputum smear-positive but IGRA-negative may possibly be infected by non-tuberculosis mycobacterium. Mycobacterium strains should be further identified; ③ In special population such as pregnant women who had no TB history
IGRA-positive result is helpful for the diagnosis of active TB.
关键词
Keywords
references
YEW W W, LEUNG C C. Update in tuberculosis 2007[J]. Am J Respir Crit Care Med, 2008, 177(5): 479-485. DOI: 10.1164/rccm.200710-1561UP.
LU E C, ZHU Y W. Diagnostic value of t-spot.tb in patients with diabetes combined with pulmonary tuberculosis[J]. J Shanxi Med Univ, 2015, 46(4): 334-336. DOI: 10.13753/j.issn.1007-6611.2015.04.014.
Chinese Society for Tuberculosis of Chinese Medical Association, Editorial Board of Chin J Tuberc Respir Dis . Proposal of interferon gamma release assay in China[J ] . Chin J Tuberc Respir Dis, 2014, 37(10): 744-747. DOI: 10.3760/cma.j.issn.1001-0939.2014.10.011.
LALVANI A, PAREEK M. Interferon gamma release assays: principles and practice[J]. Enferm Infecc Microbiol Clin, 2010, 28(4): 245-252. DOI: 10.1016/j.eimc.2009.05.012.
DE KEYSER E, DE KEYSER F, DE BAETS F. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection[J]. Acta Clin Belg, 2014, 69(5): 358-366. DOI: 10.1179/2295333714Y.0000000043.
DIEL R, LODDENKEMPER R, NIENHAUS A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis[J]. Chest, 2010, 137(4): 952-968. DOI: 10.1378/chest.09-2350.
LU P, CHEN X, ZHU L M, et al. Interferon-gamma release assays for the diagnosis of tuberculosis: a systematicreview and meta-analysis[J]. Lung, 2016, 194(3): 447-458. DOI: 10.1007/s00408-016-9872-5.
LIU J Q, ZHANG L, SUN H B, et al. Application of interferon-γ release test in early diagnosis of pulmonary[J]. Shandong Med J, 2013, 53(3): 82-84. DOI: 10.3969/j.issn.1002-266X.2013.03.033.
DHEDA K, POORAN A, PAI M, et al. Interpretation of mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results[J]. J Infect, 2007, 55(2): 169-173. DOI: 10.1016/j.jinf.2007.02.005.
ZHANG L H, HONG L Q, LUO X, et al. Application of mycobacterium tuberculosis specific protein interferon-gamma release assay in tuberculosis diagnosis and therapeutic monitoring[J]. J Radioimmunol, 2013, 26(6): 760-764. DOI: 10.3969/j.issn.1008-9810.2013.06.039.
DRUSZCZYNSKA M, WLODARCZYK M, KIELNIEROWSKI G, et al. Two-year follow-up study of mycobacterium tuberculosis antigen-driven IFN-γ responses and macrophage sCD14 levels after tuberculosis contact[J]. Indian J Microbiol, 2016, 56(2): 205-213. DOI: 10.1007/s12088-016-0571-y.
ZHOU W, ZHANG P, SONG S H, et al. Analysis of lymphocyte count in 300 lung cancer patients[J]. Chin J Lung Cancer, 2009, 12(10): 1127-1129. DOI: 10. 3779/ j. issn. 1009-3419.2009.10.15.
LIGHTER-FISHER J, SURETTE A M. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy[J]. Obstet Gynecol, 2012, 119(6): 1088-1095. DOI: 10.1097/AOG. 0b013e3182546aff.
SHI Z X, DAI D M, XU W B, et al. A case report of tuberculosis patients with post-pregnancy anti-immune recovery disease[J]. Anhui Med Pharma J, 2013, 17(7): 1205-1206. DOI: 10.3969/j.issn.1009-6469.2013.07.053.
Moderated-mediating effect of influencing factors and coping styles of treatment adherence in pulmonary tuberculosis patients based on knowledge-attitude-practice model
Epidemiological characteristics of tuberculosis in a hospital in Lhasa during 2008 and 2020
Association of single nucleotide polymorphisms of suppressor of cytokine signaling 1 gene with pulmonary tuberculosis in Liangshan Yi ethnic minority
Diagnostic value of whole blood gamma interferon-inducible protein 10 release assay in active pulmonary tuberculosis
microRNA expression in peripheral blood mononuclear cells from pulmonary tuberculosis children